High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis-Reference-Cited by-同舟云学术

High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis

Published:2007-04-02 Issue:5 Volume:23 Page:1057-1065
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Chen Hua¹,Suda Katie J.²,Turpin Robin S.³⁴,Pai Manjunath P.⁵,Bearden David T.⁶,Garey Kevin W.¹

Affiliation:

1. University of Houston, Houston, TX, USA

2. University of Tennessee Health Science Center, Memphis, TN, USA

3. Merck & Co., West Point PA, USA

4. Jefferson Medical College, Philadelphia, PA, USA

5. University of New Mexico, Albuquerque, NM, USA

6. Oregon State University, Portland, OR, USA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079907X182130

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study;PLOS ONE;2017-05-22

2. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Fluconazole;Journal of Pharmaceutical Sciences;2014-12

3. Pro-inflammatory action of Candida albicans DNA in zymosan-induced arthritis;Inflammation Research;2012-03-04

4. Candida Pneumonia in Patients with Hematological Neoplasia;Pulmonary Involvement in Patients with Hematological Malignancies;2010-12-22

5. Expensive care — a rationale for economic evaluations in intensive care;Critical Care and Resuscitation;2010-03